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The delivery of metal ions using cell membrane-permeable
metal complexes represents a method for activating cellular
pathways. Here, we report the synthesis and characterization of
new [CoIII(salen)(acac)] complexes capable of up-regulating the
ubiquitin ligase adaptor protein Ndfip1. Ndfip1 is a neuropro-
tective protein that is up-regulated in the brain after injury and
functions in combination with Nedd4 ligases to ubiquitinate
harmful proteins for removal. We previously showed that
Ndfip1 can be increased in human neurons using CoCl2 that is
toxic at high concentration. Here we demonstrate a similar
effect can be achieved by low concentrations of synthetic CoIII
complexes that are non-toxic and designed to be activated fol-
lowing cellular entry. Activation is achieved by intracellular
reduction of CoIII to CoII leading to release of CoII ions for
Ndfip1 up-regulation. The cellular benefit of Ndfip1 up-regu-
lation by CoIII complexes includes demonstrable protection
against cell death in SH-SY5Y cells during stress. In vivo, focal
delivery of CoIII complexes into the adult mouse brain was
observed to up-regulate Ndfip1 in neurons. These results dem-
onstrate that a cellular response pathway can be advantageously
manipulated by chemical modification of metal complexes, and
represents a significant step of harnessing low concentration
metal complexes for therapeutic benefit.
Transitionmetals are essential for many important chemical
processes in biological systems. Most of these metal-related
processes occur by interactions with nucleic acids and proteins.
Within the cell, metal ions can stabilize, destabilize, or modu-
late DNA and proteins by introducing conformational changes
and by creating centers of activity. Although the use ofmetals as
structural elements within the cell is well known, emerging evi-
dence now recastsmetals as signalingmolecules able to activate
critical cellular pathways. For example, metals such as iron,
copper, and cobalt can produce reactive oxygen species that
lead to the activation of redox-sensitive transcription factors
including NF-B, AP-1, and p53. Metals have also been sug-
gested to affect the upstream regulatory components of the
MAP kinase and the PI3K/Akt/mTor pathway (1, 2). Thus the
levels and regulation of metals in a cell can have a direct role on
cell function and survival.
Metal ions such as CoII and FeII can stimulate the expression
of the neuroprotective protein Nedd4 family interacting pro-
tein 1 (Ndfip1)4 in the brain (3). Ndfip1 is a transmembrane
protein that is localized to the Golgi and post-Golgi vesicles
such as endosomes (4, 5). Ndfip1 functions as an adaptor pro-
tein for the Nedd4 family of ubiquitin ligases that target pro-
teins for both degradation and trafficking (4). The metal-in-
duced up-regulation of Ndfip1 results in the activation of the
ubiquitin proteasome pathway. Ndfip1 recognizes and inter-
acts with divalentmetal transporter 1 (DMT1), this recruits the
E3 ligase Nedd4–2 resulting in degradation of DMT1, prevent-
ing iron overload within the cell (3). Other targets for Ndfip1
have also been identified, including the transcription factor
JunB that is regulated by Ndfip1 in association with the E3
ligase Itch (6). In the adult brain, Ndfip1 is endogenously pres-
ent in cortical neurons at low levels, however it is up-regulated
in a subset of neurons upon activation by injury or stress (7).
Importantly, this up-regulation of Ndfip1 has been shown to be
neuroprotective, and neurons with up-regulated Ndfip1 do not
undergo apoptosis.
Whereas high levels of exogenous CoII and FeII are toxic to
cells, our previous results show they also stimulate Ndfip1 via
still unknownmechanisms. Barring the effects ofmetal toxicity,
this finding introduces an opportunity to harness the capacity
of metal ions to up-regulate Ndfip1 for neuroprotective pur-
poses. In the present study, we investigate the utility of non-
toxic metal complexes for controlled intracellular delivery of
cobalt to stimulate Ndfip1 expression. This was based on the
premise that the reactivity of metal ions can be modulated by
the formation of coordination complexes, with a complexed
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metal ion having remarkably different reactivity to the “free”
metal ion or hydrated cation. The incorporation of metal ions
into coordination complexes permits superior control over
their reactivity, and minimizes unwanted interactions with
other molecules (8). Furthermore, the coordination of metal
ions to ligands permits manipulation of their distribution and
diffusion properties across cell membranes.
Here we report the design and synthesis of metal complexes
capable of delivering cobalt ions into the cell that are bioactive
at far lower concentrations than the free metal salts. We dem-
onstrate that this approach is capable of delivering low, but
biologically effective levels of cobalt into the cell, resulting in
Ndfip1 up-regulation with sustainable biological effects. As
proof of concept, we show that cobalt-induced Ndfip1 up-reg-
ulation provides protection against cell death from noxious
stimuli such as hydrogen peroxide. Our approach centers on
the coordination of metal ions with suitable ligands as a pow-
erful means of drug design that can overcome traditional
hurdles of metal toxicity without compromising biological
outcomes.
EXPERIMENTAL PROCEDURES
General Synthetic Procedures—All reagents and solvents
were obtained from standard commercial sources and unless
otherwise stated were used as received. 1H and 13C NMR spec-
tra were recorded with a Varian Unity 400 or 500 spectrometer
(1H at 500 MHz and 13C at 126 MHz). All NMR spectra were
recorded at room temperature. The reported chemical shifts (in
parts per million) are referenced relative to residual solvent
protons. Mass spectra were recorded using the electrospray
technique (positive and negative ion) with a Micromass
QUATTRO II triple-quadropole electrospraymass spectrome-
ter. UV-Vis spectra were recorded in PB buffer (20mM, pH 7.4)
with a ShimadzuUV-1650PCUV-Vis spectrophotometer using
the UVPC c3.9 software program. HPLC was performed with
anHP 1100ChemStation systemusing a SupelcoDiscovery C18
column (150 nm  4.6 mm, 5 m). The HPLC solvents were
0.1% trifluoroacetic acid in water (solvent A) and 0.1% trifluo-
roacetic acid in acetonitrile (solvent B). The gradient was
0–100% solvent B in 0–25 min, the flow rate was 1.00 ml/min,
and the detection was at 280 nm. Microanalysis for carbon,
hydrogen, and nitrogenwere carried out by Chemical &Micro-
Analytical Services (Belmont, VIC, Australia).
Synthesis—The ligands sal L1, MeO-sal L2, and EtO-sal L3
were synthesized according to published literature procedures
(9). The corresponding aqua CoIII complexes were made fol-
lowing modified procedures by Bailes et al. (10).
To a suspension of (N, N-Ethylenebis-(R-salicylideneiminato)-
cobalt(III)(OH)(H2O) (with RH, OMe, OEt) (0.7–1 mmol) in
ethanol (10 ml) was added an excess of acetylacetone (250 l),
and the resulting solution was stirred at room temperature for
2 h. A dark green precipitate formed, which was collected by
filtration, washed with cold ethanol (5 ml), water (5 ml) and
diethyl ether (5 ml) and dried in vacuo to afford C1–3 as crys-
talline green solids.
(N, N-Ethylenebis-(salicylideneiminato)-acetylacetone)co-
balt(III)C1 (170 mg, 72%); H (500MHz; DMSO-d6) 8.03 (1 H,
s), 7.82 (1 H, s), 7.36 (1 H, dd, J 7.8, 1.9), 7.27 (1 H, dd, J 7.8, 1.8),
7.22 (1 H, ddd, J 8.6, 6.8, 1.8), 7.03–6.97 (2 H, m), 6.71–6.70 (1
H, m), 6.51–6.48 (2 H, m), 5.41 (1 H, s), 4.12–4.01 (2 H, m),
3.78–3.68 (2 H, m), 1.76 (3 H, s), 1.73 (3 H, s); C (125 MHz;
DMSO-d6) 188.8, 186.1, 166.9, 166.6, 166.2, 166.1, 134.6, 133.8,
132.9, 131.8, 124.9, 123.2, 122.1, 118.6, 114.4, 112.7, 98.4, 61.1,
59.1, 26.0, 25.5 (11).
(N, N-Ethylenebis-(2-methoxy-salicylideneiminato)-acetyl-
acetone)cobalt(III)C2 (190mg, 82%); H (500MHz;DMSO-d6)
8.05 (1 H, s), 7.77 (1 H, s), 7.01 (1 H, dd, J 8.0, 1.6), 6.90 (1 H, dd,
J 8.0, 1.6), 6.81 (1 H, dd, J 7.6, 1.6), 6.61 (1 H, dd, J 7.6, 1.6),
6.44–6.39 (2 H,m), 5.43 (1 H, s), 4.04–4.02 (2 H,m), 3.75–3.65
(2 H, m), 3.70 (1 H, s), 3.56 (3 H, s), 1.74 (3 H, s), 1.73 (3 H, s);
C (125 MHz; DMSO-d6) 189.1, 186.0, 166.9, 166.5, 157.8,
157.6, 154.7, 152.8, 126.4, 125.7, 123.9, 118.6, 116.1, 115.1,
113.7, 111.8, 98.6, 61.1, 59.3, 56.1, 55.7, 26.0, 25.4; HRMS
(ESI) m/z (MNa) 507.0942 (507.09201 calculated for
C23H25CoN2O6Na); elemental analysis found: C: 56.43%, H:
5.85%, N: 5.82%; calculated for C23H25CoN2O6: C: 57.03%,
H: 5.20%, N: 5.78%.
(N, N-Ethylenebis-(2-ethoxy-salicylideneiminato)-acetyl-
acetone)cobalt(III) C3 (200 mg, 89%); H (500 MHz; DMSO-d6)
8.05 (1 H, s), 7.79 (1 H, s), 7.02 (1 H, dd, J 8.0, 1.6), 6.95 (1 H, dd,
J 8.0, 1.6), 6.81 (1 H, dd, J 7.5, 1.6), 6.62 (1 H, dd, J 7.5, 1.6),
6.41–6.35 (2 H, m), 5.43 (1 H, s), 4.11–3.94 (6 H, m), 3.77–3.75
(2 H, m), 1.75 (3 H, s), 1.73 (3 H, s), 1.22 (3 H, t, J 7.0), 1.03 (3 H,
t, J 7.0); C (125 MHz; DMSO-d6) 189.0, 186.0, 166.9, 166.7,
159.2, 158.7, 153.2, 151.8, 127.2, 126.5, 125.2, 121.5, 119.3,
118.7, 114.0, 111.8, 98.5, 64.7, 64.5, 60.8, 59.3, 26.0, 25.5, 15.1,
14.9; HRMS (ESI)m/z (MNa) 535.12247 (535.1255 calcu-
lated for C25H29CoN2O6Na); elemental analysis found: C:
57.94%, H: 6.34%, N: 5.55%; calculated for C25H29CoN2O6: C:
58.59%, H: 5.71%, N: 5.47%. Crystals suitable for x-ray analysis
were obtained for C2 and C3 after allowing a solution of the
complex in DMSO to stand in air.
Electrochemistry—Cyclic voltammograms were recorded
with an AUTO-LAB PGSTAT100 using the GPES V4.9 soft-
ware program and employing a glassy carbon working elec-
trode, a platinum counter electrode and a Ag/Ag reference
electrode. The measurements were carried out in DMF. The
solutions contained 1 mM analyte in a 0.1 M tetrabutylammo-
nium tetrafluoroborate. TheDMFwas dried over 3Åmolecular
sieves under an atmosphere of N2 before use. Each solution was
purged with N2 prior to analysis andmeasured at ambient tem-
perature under a N2 atmosphere. Each sample was referenced
to an internal reference of ferrocene, which was taken as having
an E0  0.54 V versus SCE.
Crystallography—Intensity data were collected with an
Oxford Diffraction Sapphire CCD diffractometer using Cu-K
radiation (graphite crystal monochromator   1.54184 Å).
The temperature during data collection was maintained at
130.0(1) using an Oxford Cryostream low temperature device.
Crystal data forC2C25H31N2O7SCo,M 562.51,T 130.0(2)
K,   1.5418, Monoclinic, space group P21/n, a  9.7813(2),
b 21.0806(4) c 13.0041(3) Å,  102.962(2)°,V 2613.06(9)
Å3, Z 4, Dc 1.430MgM3(Cu-K) 6.293mm1, F(000)
1176, crystal size 0.27  0.07  0.05 mm. 18496 reflections
measured, 5151 independent reflections (Rint  0.0452) the
final R was 0.0431 [I 2(I)] and wR(F2) was 0.1058 (all data).
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Crystal data for C3 C25H29N2O6Co,M 512.43, T 130.0(2)
K,   1.5418, Monoclinic, space group C2/c, a  30.3043(6),
b  10.2537(2) c  15.5706(3) Å,   103.624(2)°, V
4702.13(16) Å3, Z  8, Dc  1.448 Mg M3 (Cu-K) 6.097
mm1, F(000)  2144, crystal size 0.54  0.12  0.04 mm.
10860 reflections measured, 4215 independent reflections
(Rint 0.0472) the final Rwas 0.0412 [I 2(I)] andwR(F2) was
0.1065 (all data).
The following crystal structures have been deposited at the
Cambridge Crystallographic Data Centre and allocated the
deposition numbers CCDC 808949 and 808950.
MATERIALS ANDMETHODS
Cell Culture and CoIII Complex Addition—SH-SY5Y cells
were cultured in RPMI media supplemented with 15% FCS, 2
mM L-glutamate, and 50 g/ml PenStrep. Cultures were main-
tained at 37 °C in a 5% CO2 atmosphere. Exposure of cells to
CoIII complexes: prior to treating with cobalt complexes, cells
were seeded into 6-well plates at 4 104 cells and incubated for
2 days. The compounds (10mM stock) were prepared inDMSO
and added to cells at 0.1–100 M. Controls used vehicle of
DMSO.
Metal Toxicity Quantification by Flow Cytometry—Toxicity
of cobalt complexes was assessed quantitatively by flow cytom-
etry using propidium iodide staining. Briefly, 4 105 cells were
grown in 6-well plates and incubated for 18 h after addition of
cobalt complexes at concentrations ranging from 10 mM-0.1
M. All cells (adherent and suspension) were harvested and
stained with 10 g/ml propidium iodide and incubated for 15
min before analysis by flow cytometry (FACSCalibur, Becton
Dickinson).
Inductively Coupled Plasma Mass Spectrometry—Cells were
incubated with cobalt complexes for 1 h in serum-free RPMI
media. The cells were scraped into phosphate buffer, an aliquot
was taken for protein determination (Protein Microassay;
Thermo Scientific), and the remaining cells collected by centri-
fugation at 1500 rpm for 3min. Pellets were washed three times
in PB buffer. Themetal levels were determined in cell pellets by
ICP-MS as described previously (12) and converted to fold
increase in metal compared with untreated controls.
CoII Release, Fluorescence Quenching Assay—Cells were
loaded with 0.25 M calcein-AM (1 mM stock solution in
DMSO) for 30 min at 37 °C in RMPI media. Cells were then
washed and resuspended in MES buffer (20 mM MES, 150 mM
NaCl, pH 6.7) and 2  105cells were transferred to a 96-well
flat-bottom transparent plate in triplicate, and fluorescence
was recorded using a fluorescence spectrometer microplate
reader (excitation 488 nm, emission 518 nm). When fluores-
cence stabilized, cobalt complexes (10 M) and vehicle were
added to the cell suspension and fluorescencewas continuously
monitored for 500 s.
Western Blot Assays—Assays to determine Ndfip1 overex-
pression in response to cobalt complexes were conducted by
treating cells with complexes C1-3 at varying concentrations
for 2–18 h before analysis by Western blot. Prior to treatment,
cells were seeded into 10-cm dishes. The compounds were pre-
pared in DMSO at a stock concentration of 10 mM and control
cells were treated with DMSO vehicle at 0.1% (v/v). Cells were
harvested at indicated time points, washed with ice-cold PBS
and lysed in RIPA buffer (50mMTris, pH 8, 100mMNaCl, 5mM
EDTA, 1% Triton X-100, 0.2% SDS, Protein Inhibitor mixture
(Roche)) for 20 min on ice. Cell debris was removed by centri-
fugation (13,000 rpm, 15min, 4 °C). Cell lysates were subject to
SDS-PAGEbefore transfer to nitrocellulosemembranes.Mem-
branes were incubated with rabbit polyclonal Ndfip1 antibody
(3), HSP70 and HIF1- antibody, followed by the appropriate
HRP secondary antibody (Upstate). Blots were detected using
Amersham Biosciences ECL reagent (GE Healthcare). All blots
are representative of at least three different experiments.
Hydrogen Peroxide Toxicity Assay—SH-SY5Y cells and
SH-SY5Y inducible cell line (4  105) were grown in 6-well
plates and incubated for 18 h with or without complexC3 at 10
M before the addition of H2O2 at concentrations ranging from
5–25 M. After 1 h of incubation at 37 °C cells were collected
(both adherent and suspension) by trypsinization, centrifuged,
and labeledwith 10g/ml propidium iodide for 15min at room
temperature. Stained cells were quantitatively analyzed by flow
cytometry (FACSCalibur, Becton Dickinson).
Compound Injections and Immunohistochemistry—Using a
fine glass pipette, coupled to a hamilton syringe, the cortex of
adult mouse brains were stereotaxically injected with 3 l of
either 10 M or 50 M of complexC3, 500 M CoCl2 or DMSO
as a vehicle control. Stereotaxic injection co-ordinates in rela-
tion to bregma were, anterior1.0 mm, lateral1.5 mm, ven-
tral from the dura1.25 mm. Six hours after injections brains
were collected and frozen in OCT before sectioning at 14 m.
Sections were fixed in 4% paraformaldehyde for 20 min and
blocked in 10% normal horse serum in 0.1 M phosphate buffer
with 0.2% Triton X-100, and then incubated overnight with rat
monoclonal Ndfip1 (1:500) primary antibody. Antibody was
detected with Alexa Fluor 594-conjugated goat anti-rat IgG
(1:500; Invitrogen). TUNEL was used as a marker of cell death
and to determine injection sites. Brain sections were imaged
using an Olympus BX51 microscope. Ndfip1 positive neurons
weremeasured for intensity using ImageJ (13).Neurons close to
the injection site (50 m) were not counted due to injury
induced by the needle track.
RESULTS
Chemical Synthesis and Characterization—The complex
design is crucial for the proposed delivery of CoII. We chose to
employ one tetradentate dianionic ligand andonemonoanionic
bidentate ligand for the preparation of stable, neutral, lipophilic
six coordinate CoIII complexes (Fig. 1A). These low molecular
weight complexes ( 500Da), were designed to have ideal char-
acteristics formembrane and blood-brain-barrier permeability.
Tetradentate Schiff-base ligands derived from salicylalde-
hyde and aliphatic amines are well known (14). Cobalt com-
plexes of tetradentate Schiff-base ligands have been investi-
gated as mimics of vitamin B12 coenzymes and certain CoIII
Schiff-base complexes are known to have antiviral, antibacte-
rial, and antitumor properties (15, 16). The Schiff-base ligands
coordinate to CoII or CoIII ions through two amine nitrogen
atoms and two phenolic oxygen atoms. This family of proli-
gands can be readily modified with a variety of functional
groups on the aromatic ring as well as the amine backbone to
Ndfip1 Up-regulation using Bioactive Cobalt Complexes
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alter lipophilicity, cell permeability, and ultimately biodistribu-
tion. The final two donor sites of octahedral CoIII were supplied
by the bidentate ligand anionic acetylacetonate.
The synthesis of C1-3 was carried out as shown in Fig. 1B.
Ligands were synthesized according to published literature
procedures followed by complexation to Co(OAc)2 (9). Oxida-
tion in air in MeOH:H2O (9:1) followed by the addition of ace-
tylacetone gave the desired neutral complexes (10). All three
complexes are diamagnetic as predicted for a low spin d6 CoIII
system and were characterized by 1H and 13C NMR spectros-
copy as well as electrospray mass spectrometry and microanal-
ysis. Crystals suitable for single crystal x-ray structure determi-
nation of complexes C2 and C3 were grown from a saturated
solution of the complex in dimethyl sulfoxide. X-ray analysis of
compound C3 shows a neutral cobalt complex with a six-coor-
dinate CoIII ion in a distorted octahedral environment (Fig. 1C,
Table 1, supplemental Fig. S1,C2 structure). The salen ligand is
doubly deprotonated and adopts a twisted arrangement, where
the-diketone occupies two cis-positions of the distorted octa-
hedron around the cobalt atom and the polyhedron being com-
pleted by the quadridentate ligand.
Complexes C1–3 Are Stable, Nontoxic, and Allow Cobalt
Entry—The cobalt complexes were designed to be kinetically
inert to substitution while the cobalt remained in the 3 oxi-
FIGURE 1. Molecular design of cobalt-complexes. A, structures of cobalt Schiff-base complexes C1–3. B, synthetic scheme for the synthesis of cobalt
complexesC1–3.C, anORTEP representation of themolecular structure ofC3with thermal ellipsoids at 40%probability level. Solvent andhydrogen atoms are
omitted for clarity.
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dation state. This should lead to a stable neutral complex capa-
ble of diffusing into cells. The electronic absorption spectra of
the complexes and uncomplexed ligands gave important infor-
mation regarding their stability. The electronic absorption
spectrum of the ligands L1-L3 in DMSO consist of two intense
bands centered at about 260 and 320 nm, assigned to the 	3
	* transitions of the phenol ring and the azomethine group
respectively. The CoIII complexes of these ligands (C1-3)
exhibit absorption bands that are red shifted by about 80 nm
and appear around 400 nm. These 	3 	* azomethine transi-
tion bands, show a shoulder at 420 nm, which is attributed to
metal-ligand charge transfer transitions (d 3 	*). Electronic
spectra recorded in 20mMphosphate buffer (pH 7.4) are slighty
shifted with the	3	* azomethine transition bands located at
around 390 nm in theCoIII complexes. To show that complexes
C1-3 are stable, samples at 10 M concentration in phosphate
buffer were incubated at 37 °C for 24 h. Electronic absorption
spectra recorded at 0, 1, and 24 h time points were unchanged
suggesting that the complexes remained intact (Fig. 2A). It is
interesting to note however, that the electronic spectra of the
uncomplexed ligands L1-L3 in PB buffer showed appreciable
changes in a short time at room temperature (Fig. 2B). The
existence of two well defined isosbestic points indicates that
the ligands are susceptible to hydrolysis in aqueous buffer (sim-
ilar profile for L3 at 30 min to 3-ethoxysalicylaldehyde) and
consequently are unlikely to be stable for appreciable amounts
of time once released in the cell.
To determine whether cobalt complexes C1-3 were cell
membrane permeable we incubated SH-SY5Y cells with each
compound (50 M, 1 h) and measured intracellular cobalt
levels by inductively coupled plasma mass spectrometry
(ICP-MS). As expected untreated cells had extremely low
levels of cobalt (0.18 ng cobalt/mg protein) (Fig. 2C). Signif-
FIGURE 2. Cobalt complex stability, uptake, and cell viability. A, electronic absorption spectra of complex C3 in phosphate buffer. The spectra of complex
C3 remains unchanged after incubation at 37 °C for 24 h, demonstrating the stability of the cobalt complex. B, electronic absorption spectra of uncomplexed
ligand L3. The spectra of the ligand L3 shows appreciable changes over a short time at room temperature, indicating that the ligand is susceptible to hydrolysis
in aqueous buffer. C, cobalt levels in treated SH-SY5Y cells. SH-SY5Y cells were treatedwith cobalt complexesC1–3 or CoCl2 (all 50M) for 1 h. Themetal levels
were measured in washed cell pellets by ICP-MS and calculated as ng/mg protein. All cobalt complexes induced significant increases in cellular cobalt levels
compared with an untreated control. D, cell viability assay. SH-SY5Y cells were treated with complexes C1–3 for 18 h at concentrations ranging from 0.1–100
M. Toxicity of cobalt complexes was assessed quantitatively using propidium iodide staining and flow cytometry.
TABLE 1
Crystallographic data for cobalt complexes C2 and C3
C2 C3
Co(L2)(acac)	.DMSO Co(L3)(acac)	
Chemical Formula C25H31CoN2O7S C25H31CoN2O6
M 562.51 512.43
Crystal System Monoclinic Monoclinic
Temperature/K 130(2) 130(2)
Space Group P 21/n C 2/c
a/Å 9.7813(2) 30.3043(6)
B/Å 21.0806(4) 10.2537(2)
c/Å 13.0041(3) 15.5706(3)
/° 90 90
/° 102.962(2) 103.624(2)

/° 90 90
V/Å3 2613.06(9) 4702.13(16)
Z 4 8
Ind Refl. 5151 4251
R(int) 0.0452 0.0472
R (I 2s(I)) 0.0412 0.0412
wR (all data) 0.1065 0.1065
Ndfip1 Up-regulation using Bioactive Cobalt Complexes
MARCH 11, 2011•VOLUME 286•NUMBER 10 JOURNAL OF BIOLOGICAL CHEMISTRY 8559
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
icant increases of cobalt levels were observed for all three
cobalt complexes when compared with CoCl2-treated cells
(Fig. 2C). The highest levels were induced by treatment with
the more lipophilic complex C3 where a 12-fold increase in
intracellular cobalt levels was detected compared with
CoCl2. This corresponds to cellular cobalt levels of 38 and
470 ng of cobalt/mg protein for CoCl2 and cobalt complex
C3 respectively. Both complex C1 and C2 showed a 6–8-
fold increase in cobalt concentration compared with CoCl2.
Uptake into cells was highly facilitated by neutral complexes,
cationic complexes showed average cobalt leveles of 70 ng of
cobalt/mg protein (data not shown).
The effects of complexes C1-3 on cell viability were deter-
mined by a dose-dependent cell survival assay using quantita-
tive flow cytometry and staining for dead cells with propidium
iodide. Each complex showed no toxicity up to 
20 M, after
which both complex C1 and C2 both started to affect cell sur-
vival (Fig. 2D). Complex C3 started to show negative cell sur-
vival effects at concentrations above 50 M. At 100 M both
complexC1 andC2 showed
40% cell death, with complexC3
being the least toxicwith only 20% cell death observed after 24 h
incubation. These results show that even though complex C3
was delivering the highest level of cobalt to the cell it was the
least toxic.
Cobalt Complexes Are Reducible by Intracellular Reductants—
The electrochemical behavior of complexes C1-3 was studied
by cyclic voltammetry (CV). Cyclic voltammograms were
acquired in dimethylformamide solutions of the complexes at a
glassy carbon electrode. The cathodic peak potential Epc for
each complex was obtained from the CV and referenced to the
ferrocene/ferrocenium couple (E0  0.54 V versus SCE) and
these values are summarized in Table 2. Each of the complexes
displayed an irreversible reduction attributed to a CoIII3 CoII
process at about Epc  0.80 V. More reversible processes
tentatively attributed to [CoIIL]  e 3 [CoL] and to
[CoIIIL]3 [CoIVL]2 could also be detected, but are less rel-
evant to the present application of complexesC1-3. Irreversible
redox couples are typical for many CoIII complexes, as electro-
chemical reduction is often followed by a chemical change as a
consequence of the lability of CoII. The Epc values for C1-3
should be accessible for reduction by cellular reductants. The
values encountered are within range of other metal complexes
that have been shown to be reduced intracellularly (17, 18).
In addition, electronic absorption spectra showed that al-
though complexes C1-3 were stable for extended periods in
aqueous solution, as anticipated, the biologically relevant
reductant cysteine reduced complexes C1-3. Upon addition of
cysteine an immediate change in the electronic absorption
spectra was observed, consistent with reduction to CoII and
ligand exchange (supplemental Fig. S2).
CoII Is Released fromComplexes following Reduction by Intra-
cellular Reductants—Our approach of delivering bioavailable
CoII is based on cobalt having a kinetically inert higher oxida-
tion state, CoIII and a more kinetically labile lower oxidation
state, CoII. Kinetically inert transitionmetal complexes, such as
CoIII are known to undergo the water exchange reaction rela-
tively slowly, with half-lives of about 1 day (19). In contrast, the
divalent oxidation state is known for its labile metal complexes
with ligand exchange occurring rapidly. This means that for
redox cycling to occur, back-oxidation would have to be
quicker then the rate of ligand release, which is unlikely consid-
ering the rate of aquation of cobalt complexes is in the order of
106 s1 (20). To determine whether CoII is released following
reduction by intracellular reductants we carried out a fluo-
rescence quenching assay (21). The acetomethoxy derivate
of calcein (calcein-AM) is non fluorescent and can be trans-
ported through the cellular membranes, where intracellular
esterases remove the acetomethoxy groups resulting in a
strong green fluorescence. It is known, that the fluorescence
of calcein is quenched strongly by divalent metal ions such as
CoII, NiII, and CuII at physiological pH (22). The addition of
C1-3 (10 M) to SH-SY5Y cells, loaded with calcein dye at
250 nM resulted in a rapid quenching of fluorescence indi-
cating that cobalt was released from each of the complexes
(Fig. 3, A and B). Both complexes C1 and C2 showed very
similar rates of fluorescence quenching and as observed
above (Fig. 2C) they also have similar levels of cobalt entry,
therefore they appear to be reduced inside the cell at a sim-
ilar rate. Complex C3 displayed the most rapid fluorescence
quenching indicating that it can be rapidly reduced to release
the cobalt ion once inside the cell. This complex however
also has the highest level of cobalt delivery to the cell (Fig.
2C) so a combination of rapid cell entry and intracellular
reduction may be occurring for this complex. A control
experiment confirmed that calcein-fluorescene was not
quenched by the CoIII complexes C1–3 in a cell-free assay
carried out in phosphate buffer (data not shown).
Cobalt Complexes C1–3 Are Potent at Increasing Ndfip1
Expression—Complexes C1-3 were designed to deliver bio-
available cobalt to cells in order to upregulate the levels of
Ndfip1 protein. To determine the affect of complexesC1–3 on
Ndfip1 expression we incubated SH-SY5Y cells with 10 M of
each complex for 4 h. For comparison cells were also incubated
with 200 M of CoCl2 that we have previously shown to stimu-
late Ndfip1 expression. All three complexes were able to up-
regulate Ndfip1 compared with control cells with complex C2
and C3 able to stimulate Ndfip1 up-regulation above the levels
of CoCl2 (Fig. 4,A and B). Similar results were observed when 1
M of each complex was incubated for 18 h, the free ligand
without cobalt was observed to show no increase in Ndfip1
expression (supplemental Fig. S3). Addition of cycloheximide
(CHX) to cultures inhibited the up-regulation of Ndfip1 pro-
tein levels indicating that the increase in Ndfip1 was a result of
new protein expression and not due to enhanced stability of
Ndfip1 protein (Fig. 4, C and D).
Addition of cobalt to cells in normoxic conditions results in
the stabilization of the -subunit of hypoxia inducible factor
(HIF-1) by blocking its ubiquitination and proteasomal degra-
TABLE 2
Cathodic peak potentials Epc of the Co(III) complexes in DMF
Epc(mV) vs. Fc/Fc
Co(salen)(acac) C1 835
Co(MeO-salen)(acac) C2 814
Co(Eto-salen)(acac) C3 864
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dation (23). We investigated the affect of complex C1-3 and
CoCl2 onHIF1- levels in SH-SY5Y cells after 6 h of incubation.
As expected CoCl2 was observed to increase the levels of
HIF1- (either 200 or 400M), surprisingly all three complexes
failed to show an increase the levels of HIF1- (Fig. 4E) despite
showing an increase in the levels of intracellular cobalt (Fig.
2C). To further study the cellular response occurring due to
cobalt complexeswe investigated the activation ofHSP-70 after
incubationwith either CoCl2 or complexC3 for 18 h. HSP-70 is
known to be activated due to heat shock as well as a general
stress response and in SH-SY5Y cells we observed robust up-
regulation of HSP-70 levels after both heat shock and CoCl2
(200M) treatment (Fig. 4F). ComplexC3was also observed to
activate HSP70 at 100 M although at a lower level compared
with heat shock or CoCl2 treatment, lower concentrations of
complex C3 did not result in HSP70 levels above control levels
(Fig. 4F).
Cobalt Complexes Protect SH-SY5YCells fromH2O2-induced
Toxicity—Using an inducible SH-SY5Y cell line, where Ndfip1
expression is up-regulated following induction with 4-hydroxy
tamoxifen, we showed protection from H2O2 induced toxicity
(Fig. 4G). To investigate the biological effect of Ndfip1 up-reg-
ulation as a response to cobalt complex exposure we incubated
SH-SY5Y cells with complex C3 for 18 h at a concentration of
10 M before the addition of 5–25 M H2O2 to the culture
media for 1 h. Cell survival was assayed by flow cytometry and
staining with propidium iodide for cell death. Cells treatedwith
complex C3 showed a significant decrease in cell death com-
pared with control cells (Fig. 4H). The level of protection
observed after complex C3 treatment was similar to that
observed for the Ndfip1 induced cells. Overall these findings
indicate that the treatment of complex C3 results in the
involvement of Ndfip1 in mediating cell signaling pathways
that ultimately lead to cell survival.
In Vivo Up-regulation of Ndfip1 in Neurons Treated with
Complex C3—To determine if complex C3 could up-regulate
Ndfip1 in vivo we used stereotaxic injections of control vehicle
(2% DMSO), or vehicle containing 10M or 50M complexC3
or 500MCoCl2 into the cortex of adult mice. Levels of Ndfip1
expression were determined through immunohistochemistry
and quantitative analysis of fluorescence levels using ImageJ.
We observed that 500MCoCl2 was able to up-regulateNdfip1
levels in vivo (Fig. 5, A–C) supporting our previous findings of
CoCl2 up-regulation of Ndfip1 in human primary neuron cul-
tures (3). Injection of complexC3 at both 10 and 50Mwas able
to significantly up-regulate Ndfip1 at levels comparable to 500
M CoCl2, whereas vehicle was found to have no effect on
Ndfip1 levels (Fig. 5, A–C).
DISCUSSION
The regulation of protein expression in the cell is essential
not only for normal homeostasis but also critical at times of
stress when cells are challenged by adverse environments. Here
we report a novel application of cobalt metal complexes to up-
regulate protein expression of Ndfip1, a known neuropro-
tectant (3, 7). The designed compoundswere effective atmicro-
molar levels in their ability to up-regulate Ndfip1 expression.
We have previously demonstrated that Ndfip1 can be up-regu-
lated in response to metal-induced stress from iron and cobalt
exposure, and the up-regulation is effective in protecting neu-
rons from metal toxicity (3). How this is achieved remains
unclear, but one possibility is ubiquitin-mediated degradation
of harmful proteins following binding toNdfip1 (24). For exam-
ple, a proposed mechanism for cell protection is binding of
up-regulated Ndfip1 to the metal transport protein DMT1,
leading to its ubiquitination and degradation in the protea-
some, thereby limiting further metal entry (3). This suggests
that manipulating intracellular levels of metal ions within sub-
toxic thresholds can control Ndfip1 expression, providing
leverage to intracellular events lying downstream of Ndfip1
activity. However, a key challenge in activating Ndfip1 levels is
the high concentration (and toxic levels) of metal ions required
for up-regulation. Therefore, a novel aspect of the present work
is the exploitation of relatively benign metal complexes for cel-
lular entry leading to metal ion release under the reducing con-
ditions present within the cell. This approach is based on cobalt
FIGURE 3. CoII is released from complexes C1–3 following reduction by intracellular reductants. A, calcein fluorescence quenching assay. SH-SY5Y cells
were loadedwith themetal-sensitive fluorescentdye calcein (introducedas0.25Mcalcein-AM) for 30minat 37 °C. Cellswerewashedand resuspended inMES
buffer. A total of 10Mcobalt complexC1–3wasadded to the cells and the rateof fluorescencequenchingmeasuredat 560nm.B, analysis of the rateof calcein
fluorescence quenching from B.
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having an inert higher oxidation state CoIII and a less stable
lower oxidation state, CoII. Complexes have been designed to
be neutral, membrane permeable and yet kinetically inert to
substitution in their CoIII oxidation state. Once inside the cell,
complexes are reduced to the corresponding CoII complexes
that are substitutionally labile and as a consequence release
bioactive CoII.
The success of this Trojan horse approach hinges not only on
effective delivery of biologically inert CoIII metal complexes
into the cell, but also demonstration that once inside the cell,
the complexes are converted into biologically active CoII. Evi-
dence in support of this was obtained using cyclic voltammetry
and electronic absorptionmeasurements showing that theCoIII
metal complexes are susceptible to reduction by intracellular
FIGURE 4.Ndfip1 is up-regulated by complexes C1–3. A, SH-SY5Y cell lysates after exposure to cobalt chloride (CoCl2) and complexes C1-3 for 4 h results in
increasedNdfip1 expression. Representative blots are shown from three independent experiments. B, quantification ofWestern blots in A (Dunnett’smultiple
comparison test, p 0.05, *; p 0.01, **). C, increase in Ndfip1 protein inmetal-treated cells is due to increased protein expression. SH-SY5Y cells treatedwith
C3orCoCl2 up-regulateNdfip1. TreatmentwithCHX for 6hprevents the increasedexpressionofNdfip1 in response toC3orCoCl2.D, quantificationofWestern
blots in C (t test, p 0.05, *). E, levels of HIF1- protein after exposure to metals. Cobalt complexes C1–3 do not show an increase in the levels of the hypoxia
inducible protein HIF1- after incubation for 6 h. F, activation of HSP70 after exposure tometals. HSP70was robustly up-regulated after heat shock (42 °C) and
after exposure to CoCl2. Complex C3 activates HSP70 at 100M, although at lower level compared with heat shock or CoCl2 treatment. Lower concentrations
of complex C3 did not activate HSP70 above control levels. G, hydrogen peroxide insult of SH-SY5Y cells. Flow cytometry analysis of SH-SY5Y cells induced by
4-hydroxy tamoxifen to overexpress Ndfip1 before exposure to H2O2 stress for 1 h. Cells induced to express Ndfip1 showed significantly less cell death
comparedwith uninduced control.H, flow cytometry analysis of SH-SY5Y cells treatedwith 10M complex C3 for 18 h prior to insult with hydrogen peroxide.
Cells treated with complex C3 show a significant reduction in cell death compared with untreated controls. Two-way ANOVA tests (Bonferroni post-tests)
indicate significant protection by Ndfip1 at higher concentrations of hydrogen peroxide (E) and (F) (p 0.05, *; p 0.01, **; and p 0.001,***; S.E.). Each flow
cytometric analysis represents three independent experiments.
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reductants to the labile CoII oxidation state. Additional evi-
dence of metal release was provided by a fluorescence quench-
ing assay to directly monitor the release of CoII (21). Of the
three complexes under study, complex C3 showed the highest
rate of calcein fluorescene quenching, suggesting that C3 has a
greater rate of CoII release. The greater potency of complex C3
is most likely related to its design involving ethyl substituents,
rendering it more membrane permeable, or alternatively, more
susceptible to reduction once inside the cell. As only CoII is
capable of quenching the calcein fluorescence the data con-
firms that dissociation of the metal from the ligands inside the
cell allows for the release of bioavailable CoII.
Ndfip1up-regulationby complexC3 is biologicallymeaningful,
as demonstrated by its ability to protect cultured cells from death
following exposure to hydrogen peroxide in vitro. The degree of
protection is comparable to the effect observed within cells engi-
neered to overexpressNdfip1 by geneticmeans (3).We found that
following stereotaxic injection of complex C3 into the cortex,
Ndfip1 was up-regulated in neurons situated over an area 
600
m2 adjacent the injection site, suggesting its capacity to function
in vivo. This effect was also elicited by high concentrations of the
CoCl2 salt, suggesting that complexC3 is equally effective in per-
fusing the cell matrix as the free salt. Currently it is unclear
whether complexC3has the capability to remain stable and travel
through intercellular spaces to activate neurons further from the
injection site.
A further advance in using the present approach is the low
(micromolar) concentrations of cobalt complexes required for
generating a biological effect when comparedwith the use of sim-
ple metal salts such as CoCl2. This is related to the high efficiency
of cobalt complex uptake followed by complex reduction inside
the cell releasing bioavailableCoII.We found this to be the case for
all threecomplexes tested,whichdespite subtledifferences in their
design, are capable ofNdfip1up-regulation at 1Mconcentration,
comparedwith200MforCoCl2.Their effectiveness atmicromo-
lar concentrations presents significant therapeutic potential with-
out the side effects ofmetal toxicity. Our findings also have strong
implications for the current use of high (200–500 M) levels of
CoCl2 for experimental modeling of hypoxia (25–27). In those
studies it is frequently assumed that cobalt ions simulate hypoxic
stress by direct activation of the promoter elements of HIF1-
gene or by redox activity of excess CoII causing reactive oxygen
species production. By contrast the current study demonstrates
that cobalt complexes C1-3 at concentrations of 10 M, where
higher levels of the metal are entering the cell compared with
CoCl2 incubation, do not upregulate the stress reporter protein
HSP70 or the hypoxia-stimulated protein HIF1- (28, 29). These
results suggest that unlike treatment with CoCl2, the up-regula-
FIGURE 5. In vivo up-regulation of Ndfip1 by complex C3 in the mouse cortex. A, stereotaxic injections of complex C3 (10 M and 50 M), CoCl2 and
DMSO vehicle were performed and brains removed after 6 h. Immunohistochemical staining for Ndfip1 of the injected brains, noninjected hemispheres
were used as the controls (scale bar, 10 m). B, coronal brain slice illustrating the injection site (arrow) as highlighted by TUNEL staining. Regions A and
B indicate the area were Ndfip1 positive neurons have been counted (
600 m2). C, Ndfip1 staining intensity counts for neurons from regions A and B
for complex C3, CoCl2 and DMSO vehicle. Injections were performed on 3 animals per sample, and two sections per animal surrounding the injection site
were counted. Data represent  S.E., one-way ANOVA test (Dunnett’s post test) with significant up-regulation of Ndfip1 following C3 and CoCl2
administration (**, p  0.01).
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tion of Ndfip1 using cobalt complexes C1-3 is unlikely to be the
result of a general cell stress response. It can also been inferred
from the results that activation of HIF1- or indeed HSP70
requires metal entry via a transporter on the cell surface for effec-
tive response. Significantly, these findings open up new opportu-
nities for studying how cobalt ions cause cellular hypoxic stress
and how cells are able to sense their surrounding environment.
The potential for cobalt coordination complexes as therapeutic
agents has previously been investigated by others (30, 31). It is
noteworthy that in those complexes, themetal ionplays the role of
a carrier and provides an inert framework for transportation of a
cytotoxic agent, suchasnitrogenmustards, but performsnodirect
action in the biological system. In the case of nitrogen mustards
the formation of a coordination bond between the CoIII ion and a
nucleophilic amine or oxygen masks the cytotoxicity of the com-
pound and allows for bioreductive activation. In contrast, we syn-
thesized CoIII complexes designed to deliver CoII in the cellular
environment. The complexes presented here employ one tetra-
dentate dianionic ligand and one monoanionic bidentate ligand
resulting in the formation of stable, neutral, lipophilic six coordi-
nate CoIII complexes. The tetradentate system are well known
ligands derived from the condensation of 1,2-diaminoethanewith
substituted salicaldehydes to give proligands often given the trivial
name salenH2. ComplexC1 has previously been synthesized with
unknown biological activity, but complexesC2 andC3 are novel.
ComplexesC2 andC3bearmethyl/ethyl substituents in the 2-po-
sitionof thephenol ring to influence their lipophilicity and cellular
uptake. All three complexes are membrane permeable, shown by
measuring intracellular cobalt levelsusing ICP-mass spectrometry
of treated SH-SY5Y cells. However complex C3 was observed to
have properties that allow for a greater amount and rate of cobalt
entry.
The present work may be interpreted in the wider context of
using metal ions for therapeutic purposes (2, 32). Alterations in
metal homeostasis are connected to severe human disorders,
including cancer, diabetes and neurodegenerative diseases (33).
Changes to transition metal-ion homeostasis have been impli-
cated in a number of neurodegenerative conditions and therapeu-
tic approaches that target transitionmetal ionmetabolism, specif-
ically copper and zinc, have shown promise in the treatment of
Alzheimerdisease (1, 32). Forexample, copper-bis(thiosemicarba-
zone) complexes suchasCuII(gtsm)cancross theblood-brainbar-
rier and increase cellular metal ion bioavailability, leading to inhi-
bition of glycogen synthase kinase 3 (GSK3), which ultimately
results in degradation of A and tau phosphorylation (1). In the
present study, direct introduction of cobalt complex C3 into the
adult mouse brain was efficient in increasing neuronal levels of
Ndfip1. We propose that targeted delivery of such metals allows
for the activationof intracellular pathways andhavedemonstrated
this through the up-regulation of the neuroprotective protein
Ndfip1.
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